MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Soleno Therapeutics DIO Ratio 2011-2025 | SLNO
Annual DIO Ratio Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | 160 | 570 | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 570 | 160 | 365 |
Quarterly DIO Ratio Soleno Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 361 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.11 K | 187 | - | 169 | 1.28 K | 120 | - | 898 | 2.29 K | 1.67 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 2.29 K | 120 | 898 |
DIO Ratio of other stocks in the Diagnostics research industry
| Issuer | DIO Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Centogene N.V.
CNTG
|
25.4 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Burning Rock Biotech Limited
BNR
|
243 | $ 16.22 | 2.97 % | $ 175 M |  China |
 |
Accelerate Diagnostics
AXDX
|
198 | - | -61.36 % | $ 2.46 M |  USA |
 |
Biocept
BIOC
|
21.9 | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
245 | $ 1.57 | -3.4 % | $ 2 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
210 | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
48.7 | $ 38.53 | -0.26 % | $ 1.07 B | USA |
 |
DarioHealth Corp.
DRIO
|
165 | $ 11.99 | 0.84 % | $ 340 M |  Israel |
 |
Chembio Diagnostics
CEMI
|
97.6 | - | 0.22 % | $ 16.8 M | USA |
 |
DexCom
DXCM
|
119 | $ 66.15 | -1.22 % | $ 25.5 B | USA |
 |
Danaher Corporation
DHR
|
92.9 | $ 226.11 | -0.17 % | $ 165 B | USA |
 |
Exact Sciences Corporation
EXAS
|
240 | $ 101.52 | 0.01 % | $ 18.8 B | USA |
 |
Fulgent Genetics
FLGT
|
7.17 | $ 26.92 | -0.81 % | $ 814 M | USA |
 |
Global Cord Blood Corporation
CO
|
89.7 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
131 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
42.1 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
62.8 | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
33.5 | - | -11.32 % | $ 2.94 M | USA |
 |
CareDx, Inc
CDNA
|
48.3 | $ 19.95 | -2.97 % | $ 1.07 B | USA |
 |
Enzo Biochem
ENZ
|
156 | - | -8.98 % | $ 14.8 K | USA |
 |
Co-Diagnostics
CODX
|
304 | $ 0.31 | -9.7 % | $ 9.1 M | USA |
 |
Guardant Health
GH
|
78.4 | $ 103.94 | 1.83 % | $ 12.8 B | USA |
 |
Aspira Women's Health
AWH
|
23.1 | - | -6.19 % | $ 10.5 M | USA |
 |
Heska Corporation
HSKA
|
137 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
116 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
137 | $ 133.75 | -0.83 % | $ 21.3 B | USA |
 |
Charles River Laboratories International
CRL
|
35.3 | $ 196.94 | 2.05 % | $ 10.1 B | USA |
 |
Quotient Limited
QTNT
|
386 | - | -11.32 % | $ 1.1 M |  Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
10.4 | $ 183.42 | 0.5 % | $ 20.4 B | USA |
 |
Mettler-Toledo International
MTD
|
79 | $ 1 405.95 | 0.86 % | $ 29.8 B | Schweiz |
 |
Myriad Genetics
MYGN
|
35.8 | $ 6.96 | -3.47 % | $ 631 M | USA |
 |
Laboratory Corporation of America Holdings
LH
|
18.8 | $ 261.21 | -1.12 % | $ 21.9 B | USA |
 |
ICON Public Limited Company
ICLR
|
0.213 | $ 181.89 | -2.51 % | $ 15 B |  Irlanda |
 |
NeoGenomics
NEO
|
25.1 | $ 11.99 | 1.14 % | $ 1.52 B | USA |
 |
Neogen Corporation
NEOG
|
147 | $ 6.78 | -1.16 % | $ 1.47 B | USA |
 |
IDEXX Laboratories
IDXX
|
91.6 | $ 698.37 | -0.83 % | $ 57.6 B | USA |
 |
Lantheus Holdings
LNTH
|
44.2 | $ 67.15 | 0.79 % | $ 4.65 B | USA |
 |
Agilent Technologies
A
|
97.1 | $ 139.73 | 0.05 % | $ 42.5 B | USA |
 |
Biomerica
BMRA
|
147 | $ 2.43 | -4.8 % | $ 5.58 M | USA |
 |
Bioventus
BVS
|
175 | $ 7.53 | -0.26 % | $ 472 M | USA |
 |
Motus GI Holdings
MOTS
|
3.37 K | - | -34.28 % | $ 263 K | Israel |
 |
Pacific Biosciences of California
PACB
|
132 | $ 2.1 | -1.18 % | $ 533 M | USA |